Table of Content Chapter 1 About the Non-small Cell Lung Cancer Industry 1.1 Industry Definition and Types 1.1.1 Surgery 1.1.2 Radiofrequency ablation (RFA) 1.1.3 Radiation therapy 1.1.1.4 Chemotherapy 1.1.1.5 Targeted therapies 1.1.1.6 Immunotherapy 1.2 Main Market Activities 1.3 Similar Industries 1.4 Industry at a Glance Chapter 2 World Market Competition Landscape 2.1 Non-small Cell Lung Cancer Markets by Regions 2.1.1 USA Market Revenue (M USD) and Growth Rate 2013-2023 Sales and Growth Rate 2013-2023 Major Players Revenue (M USD) in 2017 2.1.2 Europe Market Revenue (M USD) and Growth Rate 2013-2023 Sales and Growth Rate 2013-2023 Major Players Revenue (M USD) in 2017 2.1.3 China Market Revenue (M USD) and Growth Rate 2013-2023 Sales and Growth Rate 2013-2023 Major Players Revenue (M USD) in 2017 2.1.4 India Market Revenue (M USD) and Growth Rate 2013-2023 Sales and Growth Rate 2013-2023 Major Players Revenue (M USD) in 2017 2.1.5 Japan Market Revenue (M USD) and Growth Rate 2013-2023 Sales and Growth Rate 2013-2023 Major Players Revenue (M USD) in 2017 2.1.6 South East Asia Market Revenue (M USD) and Growth Rate 2013-2023 Sales and Growth Rate 2013-2023 Major Players Revenue (M USD) in 2017 2.2 World Non-small Cell Lung Cancer Market by Types Surgery Radiofrequency ablation (RFA) Radiation therapy Chemotherapy Targeted therapies Immunotherapy 2.3 World Non-small Cell Lung Cancer Market by Applications 2.4 World Non-small Cell Lung Cancer Market Analysis 2.4.1 World Non-small Cell Lung Cancer Market Revenue and Growth Rate 2013-2017 2.4.2 World Non-small Cell Lung Cancer Market Consumption and Growth rate 2013-2017 2.4.3 World Non-small Cell Lung Cancer Market Price Analysis 2013-2017 Chapter 3 World Non-small Cell Lung Cancer Market share 3.1 Major Production Market share by Players 3.2 Major Revenue (M USD) Market share by Players 3.3 Major Production Market share by Regions in 2017, Through 2023 3.4 Major Revenue (M USD) Market share By Regions in 2017, Through 2023 Chapter 4 Supply Chain Analysis 4.1 Industry Supply chain Analysis 4.2 Raw material Market Analysis 4.2.1 Raw material Prices Analysis 2013-2017 4.2.2 Raw material Supply Market Analysis 4.2 Manufacturing Equipment Suppliers Analysis 4.3 Production Process Analysis 4.4 Production Cost Structure Benchmarks 4.5 End users Market Analysis Chapter 5 Company Profiles 5.1 Bristol-Myers Squibb 5.1.1 Company Details (Foundation Year, Employee Strength and etc) 5.1.2 Product Information (Picture, Specifications and Applications) 5.1.3 Revenue (M USD), Price and Operating Profits 5.2 GlaxoSmithKline 5.2.1 Company Details (Foundation Year, Employee Strength and etc) 5.2.2 Product Information (Picture, Specifications and Applications) 5.2.3 Revenue (M USD), Price and Operating Profits 5.3 Sanofi 5.3.1 Company Details (Foundation Year, Employee Strength and etc) 5.3.2 Product Information (Picture, Specifications and Applications) 5.3.3 Revenue (M USD), Price and Operating Profits 5.4 ZIOPHARM Oncology 5.4.1 Company Details (Foundation Year, Employee Strength and etc) 5.4.2 Product Information (Picture, Specifications and Applications) 5.4.3 Revenue (M USD), Price and Operating Profits 5.5 Alchemia 5.5.1 Company Details (Foundation Year, Employee Strength and etc) 5.5.2 Product Information (Picture, Specifications and Applications) 5.5.3 Revenue (M USD), Price and Operating Profits 5.6 Amgen 5.6.1 Company Details (Foundation Year, Employee Strength and etc) 5.6.2 Product Information (Picture, Specifications and Applications) 5.6.3 Revenue (M USD), Price and Operating Profits 5.7 Apotex 5.7.1 Company Details (Foundation Year, Employee Strength and etc) 5.7.2 Product Information (Picture, Specifications and Applications) 5.7.3 Revenue (M USD), Price and Operating Profits 5.8 BioMarin Pharmaceutical 5.8.1 Company Details (Foundation Year, Employee Strength and etc) 5.8.2 Product Information (Picture, Specifications and Applications) 5.8.3 Revenue (M USD), Price and Operating Profits 5.9 CellAct Pharma 5.9.1 Company Details (Foundation Year, Employee Strength and etc) 5.9.2 Product Information (Picture, Specifications and Applications) 5.9.3 Revenue (M USD), Price and Operating Profits 5.10 Menarini 5.10.1 Company Details (Foundation Year, Employee Strength and etc) 5.10.2 Product Information (Picture, Specifications and Applications) 5.10.3 Revenue (M USD), Price and Operating Profits 5.11 Cerulean Pharma 5.11.1 Company Details (Foundation Year, Employee Strength and etc) 5.11.2 Product Information (Picture, Specifications and Applications) 5.11.3 Revenue (M USD), Price and Operating Profits 5.12 Cipla 5.12.1 Company Details (Foundation Year, Employee Strength and etc) 5.12.2 Product Information (Picture, Specifications and Applications) 5.12.3 Revenue (M USD), Price and Operating Profits 5.13 Cornerstone Pharmaceuticals 5.13.1 Company Details (Foundation Year, Employee Strength and etc) 5.13.2 Product Information (Picture, Specifications and Applications) 5.13.3 Revenue (M USD), Price and Operating Profits 5.14 Curis 5.14.1 Company Details (Foundation Year, Employee Strength and etc) 5.14.2 Product Information (Picture, Specifications and Applications) 5.14.3 Revenue (M USD), Price and Operating Profits 5.15 CytRx 5.15.1 Company Details (Foundation Year, Employee Strength and etc) 5.15.2 Product Information (Picture, Specifications and Applications) 5.15.3 Revenue (M USD), Price and Operating Profits 5.16 Eli Lilly 5.16.1 Company Details (Foundation Year, Employee Strength and etc) 5.16.2 Product Information (Picture, Specifications and Applications) 5.16.3 Revenue (M USD), Price and Operating Profits 5.17 Exelixis 5.17.1 Company Details (Foundation Year, Employee Strength and etc) 5.17.2 Product Information (Picture, Specifications and Applications) 5.17.3 Revenue (M USD), Price and Operating Profits 5.18 Fresenius Kabi 5.18.1 Company Details (Foundation Year, Employee Strength and etc) 5.18.2 Product Information (Picture, Specifications and Applications) 5.18.3 Revenue (M USD), Price and Operating Profits 5.19 Genentech 5.19.1 Company Details (Foundation Year, Employee Strength and etc) 5.19.2 Product Information (Picture, Specifications and Applications) 5.19.3 Revenue (M USD), Price and Operating Profits 5.20 Hikma Pharmaceuticals 5.20.1 Company Details (Foundation Year, Employee Strength and etc) 5.20.2 Product Information (Picture, Specifications and Applications) 5.20.3 Revenue (M USD), Price and Operating Profits 5.21 Hospira 5.21.1 Company Details (Foundation Year, Employee Strength and etc) 5.21.2 Product Information (Picture, Specifications and Applications) 5.21.3 Revenue (M USD), Price and Operating Profits 5.22 Intas Pharmaceuticals 5.22.1 Company Details (Foundation Year, Employee Strength and etc) 5.22.2 Product Information (Picture, Specifications and Applications) 5.22.3 Revenue (M USD), Price and Operating Profits 5.23 Karyopharm Therapeutics 5.23.1 Company Details (Foundation Year, Employee Strength and etc) 5.23.2 Product Information (Picture, Specifications and Applications) 5.23.3 Revenue (M USD), Price and Operating Profits 5.24 Kyowa Hakko Kirin 5.24.1 Company Details (Foundation Year, Employee Strength and etc) 5.24.2 Product Information (Picture, Specifications and Applications) 5.24.3 Revenue (M USD), Price and Operating Profits 5.25 Ligand Pharmaceuticals 5.25.1 Company Details (Foundation Year, Employee Strength and etc) 5.25.2 Product Information (Picture, Specifications and Applications) 5.25.3 Revenue (M USD), Price and Operating Profits Chapter 6 Globalisation & Trade 6.1 Business Locations 6.2 Supply channels 6.3 Marketing strategy 6.4 Barriers to Entry Chapter 7 Distributors and Customers 7.1 Major Distributors and contact information by Regions 7.2 Major Customers and contact information by Regions Chapter 8 Import, Export, Consumption and Consumption Value by Major Countries 8.1 USA 8.2 Germany 8.3 China 8.4 Japan 8.5 India Chapter 9 World Non-small Cell Lung Cancer Market Forecast through 2023 9.1 World Non-small Cell Lung Cancer Demand by Regions Forecast through 2023 9.2 World Non-small Cell Lung Cancer Price(by Regions, Types, Applications)Analysis Forecast through 2023 9.3 World Non-small Cell Lung Cancer Revenue (M USD)(by Regions, Types, Applications) Forecast through 2023 9.4 World Non-small Cell Lung Cancer Market Analysis 9.4.1 World Non-small Cell Lung Cancer Market Revenue and Growth Rate 2013-2017 9.4.2 World Non-small Cell Lung Cancer Market Consumption and Growth rate 2013-2017 9.4.3 World Non-small Cell Lung Cancer Market Price Analysis 2013-2017 Chapter 10 Key success factors and Market Overview Tables and figures Table Main Market Activities by Regions Table Market Revenue (M USD) and Growth Rate 2013-2023 Table Major Players Revenue (M USD) in 2017 Table Market Revenue (M USD) and Growth Rate 2013-2023 Table Major Players Revenue (M USD) in 2017 Table Market Revenue (M USD) and Growth Rate 2013-2023 Table Major Players Revenue (M USD) in 2017 Table Market Revenue (M USD) and Growth Rate 2013-2023 Table Major Players Revenue (M USD) in 2017 Table Market Revenue (M USD) and Growth Rate 2013-2023 Table Major Players Revenue (M USD) in 2017 Table Major Production Market share by Players 2017 Table Major Revenue (M USD) Market share by Players 2017 Table Production Market share by Major Regions in 2013-2017 Table Production Market share by Major Regions in 2017-2023 Table Revenue (M USD) Market share by Regions in 2013-2017 Table Revenue (M USD) Market share by Regions in 2017-2023 Table Industry Supply chain Analysis Table Raw material Prices Analysis 2013-2017 Table Raw material Suppliers Market Analysis Table Manufacturing Equipment Suppliers Analysis Figure Production Process Analysis Figure Production Cost Structure Table major End Users by Regions Table Bristol-Myers Squibb Information List Figure Non-small Cell Lung CancerNon-small Cell Lung Cancer Picture, Specifications and Applications of Bristol-Myers Squibb Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Bristol-Myers Squibb 2017-2017 Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Bristol-Myers Squibb 2017-2017 Table GlaxoSmithKline Information List Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of GlaxoSmithKline Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of GlaxoSmithKline 2017-2017 Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of GlaxoSmithKline 2017-2017 Table Sanofi Information List Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Sanofi Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Sanofi 2017-2017 Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Sanofi 2017-2017 Table ZIOPHARM Oncology Information List Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of ZIOPHARM Oncology Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of ZIOPHARM Oncology 2017-2017 Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of ZIOPHARM Oncology 2017-2017 Table Alchemia Information List Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Alchemia Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Alchemia 2017-2017 Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Alchemia 2017-2017 Table Amgen Information List Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Amgen Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Amgen 2017-2017 Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Amgen 2017-2017 Table Apotex Information List Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Apotex Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Apotex 2017-2017 Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Apotex 2017-2017 Table BioMarin Pharmaceutical Information List Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of BioMarin Pharmaceutical Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of BioMarin Pharmaceutical 2017-2017 Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of BioMarin Pharmaceutical 2017-2017 Table CellAct Pharma Information List Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of CellAct Pharma Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of CellAct Pharma 2017-2017 Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of CellAct Pharma 2017-2017 Table Menarini Information List Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Menarini Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Menarini 2017-2017 Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Menarini 2017-2017 Table Cerulean Pharma Information List Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Cerulean Pharma Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Cerulean Pharma 2017-2017 Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Cerulean Pharma 2017-2017 Table Cipla Information List Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Cipla Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Cipla 2017-2017 Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Cipla 2017-2017 Table Cornerstone Pharmaceuticals Information List Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Cornerstone Pharmaceuticals Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Cornerstone Pharmaceuticals 2017-2017 Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Cornerstone Pharmaceuticals 2017-2017 Table Curis Information List Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Curis Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Curis 2017-2017 Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Curis 2017-2017 Table CytRx Information List Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of CytRx Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of CytRx 2017-2017 Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of CytRx 2017-2017 Table Eli Lilly Information List Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Eli Lilly Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Eli Lilly 2017-2017 Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Eli Lilly 2017-2017 Table Exelixis Information List Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Exelixis Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Exelixis 2017-2017 Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Exelixis 2017-2017 Table Fresenius Kabi Information List Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Fresenius Kabi Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Fresenius Kabi 2017-2017 Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Fresenius Kabi 2017-2017 Table Genentech Information List Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Genentech Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Genentech 2017-2017 Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Genentech 2017-2017 Table Hikma Pharmaceuticals Information List Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Hikma Pharmaceuticals Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Hikma Pharmaceuticals 2017-2017 Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Hikma Pharmaceuticals 2017-2017 Table Hospira Information List Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Hospira Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Hospira 2017-2017 Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Hospira 2017-2017 Table Intas Pharmaceuticals Information List Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Intas Pharmaceuticals Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Intas Pharmaceuticals 2017-2017 Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Intas Pharmaceuticals 2017-2017 Table Karyopharm Therapeutics Information List Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Karyopharm Therapeutics Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Karyopharm Therapeutics 2017-2017 Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Karyopharm Therapeutics 2017-2017 Table Kyowa Hakko Kirin Information List Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Kyowa Hakko Kirin Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Kyowa Hakko Kirin 2017-2017 Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Kyowa Hakko Kirin 2017-2017 Table Ligand Pharmaceuticals Information List Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Ligand Pharmaceuticals Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Ligand Pharmaceuticals 2017-2017 Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Ligand Pharmaceuticals 2017-2017 Table Business Locations Figure Supply channels Figure Marketing strategy Table Barriers Analysis to Entry Table Major Distributors and contact information by Regions Table Major Customers and contact information by Regions Table USA Supply, Import, Export, Consumption and Consumption Value(M USD) Table Germany Supply, Import, Export, Consumption and Consumption Value(M USD) Table China Supply, Import, Export, Consumption and Consumption Value(M USD) Table Japan Supply, Import, Export, Consumption and Consumption Value(M USD) Table India Supply, Import, Export, Consumption and Consumption Value(M USD) Table World Demand by Regions Forecast Analysis of Non-small Cell Lung Cancer (2017-2023) Table World Price by Regions Forecast Analysis of Non-small Cell Lung Cancer (2017-2023) Table World Price by Types Forecast Analysis of Non-small Cell Lung Cancer (2017-2023) Table World Price by Applications Forecast Analysis of Non-small Cell Lung Cancer (2017-2023) Table World Revenue (M USD) by Regions Forecast Analysis of Non-small Cell Lung Cancer (2017-2023) Table World Revenue (M USD) by Types Forecast Analysis of Non-small Cell Lung Cancer (2017-2023) Table World Revenue (M USD) by Applications Forecast Analysis of Non-small Cell Lung Cancer (2017-2023)